Hunan Er Kang Pharmaceutical (300267)

Currency in CNY
4.01
0.00(0.00%)
Closed·
300267 Scorecard
Full Analysis
Suffers from weak gross profit margins
300267 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.954.07
52 wk Range
2.124.83
Key Statistics
Bid/Ask
4.01 / 4.01
Prev. Close
4.01
Open
3.98
Day's Range
3.95-4.07
52 wk Range
2.12-4.83
Volume
79.79M
Average Volume (3m)
92.71M
1-Year Change
49.07%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300267 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High return over the last year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Hunan Er Kang Pharmaceutical Company Profile

Hunan Er-Kang Pharmaceutical Co., Ltd manufactures and sells APIs, finished drug products, and pharmaceutical excipients in China and internationally. Its APIs include glycerin, dilute hydrochloric acid, sulbenicillin sodium, dihydroxypropyl theophylline, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. The company’s finished drugs primarily comprise sulbenicillin sodium for injection and compound liquorice tablets. Its conventional pharmaceutical excipients include pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose; and new pharmaceutical excipients comprise hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate and its series products. Hunan Er-Kang Pharmaceutical Co., Ltd was founded in 2003 and is based in Changsha, China.

Employees
1453
Market
China

Compare 300267 to Peers and Sector

Metrics to compare
300267
Peers
Sector
Relationship
P/E Ratio
−23.8x−13.2x−0.5x
PEG Ratio
0.400.040.00
Price/Book
1.9x3.4x2.6x
Price / LTM Sales
6.8x6.8x3.3x
Upside (Analyst Target)
-−21.7%43.5%
Fair Value Upside
Unlock−10.2%6.8%Unlock

Earnings

Latest Release
Apr 22, 2025
EPS / Forecast
0.01 / --
Revenue / Forecast
353.55M / --
EPS Revisions
Last 90 days

300267 Income Statement

FAQ

What Stock Exchange Does Hunan Er Kang Pharmaceutical Trade On?

Hunan Er Kang Pharmaceutical is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Hunan Er Kang Pharmaceutical?

The stock symbol for Hunan Er Kang Pharmaceutical is "300267."

What Is the Hunan Er Kang Pharmaceutical Market Cap?

As of today, Hunan Er Kang Pharmaceutical market cap is 8.27B.

What Is Hunan Er Kang Pharmaceutical's Earnings Per Share (TTM)?

The Hunan Er Kang Pharmaceutical EPS (TTM) is -0.17.

From a Technical Analysis Perspective, Is 300267 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Hunan Er Kang Pharmaceutical Stock Split?

Hunan Er Kang Pharmaceutical has split 4 times.

How Many Employees Does Hunan Er Kang Pharmaceutical Have?

Hunan Er Kang Pharmaceutical has 1453 employees.

What is the current trading status of Hunan Er Kang Pharmaceutical (300267)?

As of 09 Aug 2025, Hunan Er Kang Pharmaceutical (300267) is trading at a price of 4.01, with a previous close of 4.01. The stock has fluctuated within a day range of 3.95 to 4.07, while its 52-week range spans from 2.12 to 4.83.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.